Metraipolis › archive › dc_f40aee809006
Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in… — Europe PMC PMID:40839775
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40839775
- DOI
- 10.1128/spectrum.00166-25
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T11:09:06.336Z
- SHA-256 of the archived text
cfe38436f566c72f8836bce0cb7226972aa8156a396066c40f13dba4fbb6b52b- Stable URL of this page
https://metraipolis.com/documento/dc_f40aee809006
How to cite
Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in… — Europe PMC PMID:40839775 — Europe PMC (en), https://europepmc.org/article/MED/40839775 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f40aee809006 (Metraipolis archive dc_f40aee809006, sha256 cfe38436f566c72f8836bce0cb7226972aa8156a396066c40f13dba4fbb6b52b)
BibTeX
@misc{dcf40aee809006,
title = {Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in… — Europe PMC PMID:40839775},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40839775},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f40aee809006; sha256 cfe38436f566c72f8836bce0cb7226972aa8156a396066c40f13dba4fbb6b52b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40839775. Agents can read the archived copy with the MCP tool read_document.